CClinicalTrials.gg
CompletedNCT04225572Updated Jan 7, 2026

Physical Rehabilitation Evaluation and Optimal Physical Therapy (PRE-OPT)

An interventional study of Physical Therapy: Dependent on Patient's Needs in Breast Cancer, sponsored by Masonic Cancer Center, University of Minnesota. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-01-07.

Sponsored by Masonic Cancer Center, University of Minnesota · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 1 year 8 months after the study started (first participant enrolled Dec 2017, registered Sep 2019).
Phase
Not applicable
Study type
Interventional
Enrollment
135
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Phase 1: The investigators will conduct a prospective study to quantify the association between axillary web syndrome (AWS) and metastatic disease and chronic morbidities such as lymphedema, shoulder dysfunction, and pain comparing women (i) with AWS and (ii) without AWS in two cohorts of women. (n=200) Phase 2: This is a randomized controlled trial to 1) quantify the effects of (i) physical therapy compared to (ii) a control group in individuals with AWS following breast cancer surgery related to physical activity and physical impairments such as lymphedema, shoulder motion, function, and pain (n=44, 22 in each group). Funding to progress to Phase 2 of this trial has been obtained. It is anticipated 120 subjects participating in Phase 1 will be screened for eligibility for Phase 2 (separate consent and eligibility from Phase 1).

02

Conditions studied

  • Breast Cancer

Browse trials for

03

In context

Breast Neoplasms

12,544 studies on the registry are indexed under Breast Neoplasms; 2,892 are open to participants now.

This study's enrollment of 135 is above the median of 72 across 9,303 interventional studies indexed under Breast Neoplasms.

Browse Breast Neoplasms studies →

Lead sponsor

Masonic Cancer Center, University of Minnesota is the lead sponsor of 284 studies on the registry; 34 are open to participants now.

Of its 39 completed or terminated interventional studies of FDA-regulated products, 28 (72%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age ≥ 18
  • Patients (female or male) with a tissue diagnosis of non-invasive or invasive breast cancer
  • Planned surgical breast cancer treatment (lumpectomy or mastectomy) with a minimum removal of one axillary lymph node by sentinel node biopsy. Contralateral prophylactic mastectomy or bilateral mastectomy is allowed.
  • Voluntary written consent signed before performance of any study-related procedure not part of normal medical care

Exclusion criteria

Exclusion Criteria:

  • Patients (patients unable to travel easily to the University of Minnesota Medical Center for post-surgery visits).
  • Synchronous bilateral breast cancer
  • Presence of a medical complication that would prevent the patient from being able to participate in the study, such as terminal cancer
  • Previous history of upper extremity deep vein thrombosis
  • Breast cancer surgery without lymph node removal
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
135 participants (actual)

Study arms

  • No intervention
    Control Group

    Patient will not receive physical therapy treatment or further instruction from the research team. The patient will receive standard care recommended by their medical provider which may or may not include physical therapy treatment.

  • Experimental
    Physical Therapy Group

    Behavioral: Physical Therapy: Dependent on Patient's Needs

Interventions

  • BehavioralPhysical Therapy: Dependent on Patient's Needs

    Therapeutic exercise: * ROM: Begin with passive upper extremity ROM and progress to active ROM. * Strengthening: Progressive upper extremity resistive exercises starting with light weights. * Aerobic: Select a suitable, individual aerobic exercise program (walking, yoga, etc.) Manual therapy * Soft tissue mobilization, myofascial release, and stretching of identified tight and stiff tissue. Lymphedema treatment * Manual lymph drainage: Gentle lymphatic massage to lymph nodes and vessels by PT for 1-2 weeks. Instruct patient in self MLD to perform 1-2×/day for 10 minutes during the remaining weeks. * Compression therapy: Gradient compression bandaging for daily wear with activities and exercise for 1-2 weeks. Instruct in self compression bandaging or issue a compression garment to wear with exercise or activity, or with worsening symptoms of AWS (i.e. cording extends down arm) or lymphedema.

06

What researchers measure

Primary outcomes

  1. Clinical characteristics of preoperative Auxillary Web Syndrome (AWS)

    Status of lymph nodes in women who have preoperative AWS (lymph node metastasis present or not)

    Time frame: 1 Year

  2. Treatment Effects

    Range of motion (ROM) will be measured using a standard goniometer

    Time frame: 1 Year

Secondary outcomes

  1. Pain level

    Measured by 0-10 scale and Penn Shoulder Score questionaire

    Time frame: 1 Year

  2. Function

    Disabilities of the Arm, Shoulder and Hand questionaire

    Time frame: 1 Year

  3. Lymphedema

    Measured by girth measures, tissue dielectic constant and bioimpedance spectroscopy

    Time frame: 1 Year

  4. Physical activity

    Measured by International Physical Activity Questionaire IPAQ (short form)

    Time frame: 1 Year

  5. Axillary web syndrome status

    (present/not present) based on palpable assessment by investigator

    Time frame: 1 Year

  6. Preoperative AWS and a positive lymph node status

    Correlation between AWS and a positive lymph node status

    Time frame: 1 Year

  7. Abduction range of motion (ROM)

    ROM measured by a standard goniometer

    Time frame: 1 month

  8. DASH Score

    Measured by Disabilities of the Arm, Shoulder, and Hand questionnaire

    Time frame: 1 Month

  9. Body mass index (BMI)

    Difference in body mass index (BMI) between patients with and without AWS (pre and post operative)

    Time frame: 1 month

07

Study locations

1 site
  • University of Minnesota Masonic Cancer Center
    Minneapolis, Minnesota 55455, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04225572
Lead sponsor
Masonic Cancer Center, University of Minnesota
Responsible party
Sponsor
First posted
Jan 13, 2020
Start date
Dec 27, 2017
Primary completion
Dec 12, 2024
Completion
Dec 12, 2025
Last update
Jan 7, 2026

Study contacts

Linda Koehler, PhD, PT, CLT-LANA
principal investigator · University of Minnesota, Division of Physical Therapy

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion